Related references
Note: Only part of the references are listed.Head-to-head comparison of three stool calprotectin tests for home use
Sjoukje-Marije Haisma et al.
PLOS ONE (2019)
A Quantitative Analysis of Colonic Mucosal Oxylipins and Endocannabinoids in Treatment-Naive and Deep Remission Ulcerative Colitis Patients and the Potential Link With Cytokine Gene Expression
Joseph Diab et al.
INFLAMMATORY BOWEL DISEASES (2019)
Relationship between endoscopic mucosal healing and histologic inflammation during remission maintenance phase in ulcerative colitis: a retrospective study
Mimari Kanazawa et al.
ENDOSCOPY INTERNATIONAL OPEN (2019)
Fecal Calprotectin in Assessing Endoscopic and Histological Remission in Patients with Ulcerative Colitis
Wing Yan Mak et al.
DIGESTIVE DISEASES AND SCIENCES (2018)
The sensitivity of fecal calprotectin in predicting deep remission in ulcerative colitis
Katrine Carlsen et al.
SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY (2018)
Expert opinion for use of faecal calprotectin in diagnosis and monitoring of inflammatory bowel disease in daily clinical practice
Catherine Reenaers et al.
UNITED EUROPEAN GASTROENTEROLOGY JOURNAL (2018)
Prognostic value of histological activity in patients with ulcerative colitis in deep remission: A prospective multicenter study
Triana Lobaton et al.
UNITED EUROPEAN GASTROENTEROLOGY JOURNAL (2018)
Discrepancies between patient-reported outcomes, and endoscopic and histological appearance in UC
Jean-Frederic Colombel et al.
GUT (2017)
Fecal calprotectin predicts complete mucosal healing and better correlates with the ulcerative colitis endoscopic index of severity than with the Mayo endoscopic subscore in patients with ulcerative colitis
Sun-Ho Lee et al.
BMC GASTROENTEROLOGY (2017)
Analytical performance and diagnostic accuracy of six different faecal calprotectin assays in inflammatory bowel disease
Matthijs Oyaert et al.
CLINICAL CHEMISTRY AND LABORATORY MEDICINE (2017)
Clinical importance of faecal calprotectin variability in inflammatory bowel disease: intra-individual variability and standardisation of sampling procedure
Vendel Kristensen et al.
SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY (2016)
Comparison of three commercial fecal calprotectin ELISA test kits used in patients with Inflammatory Bowel Disease
Hengameh Chloe Mirsepasi-Lauridsen et al.
SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY (2016)
Normalization of mucosal tumor necrosis factor-α: A new criterion for discontinuing infliximab therapy in ulcerative colitis
Trine Olsen et al.
CYTOKINE (2016)
Level of Fecal Calprotectin Correlates With Endoscopic and Histologic Inflammation and Identifies Patients With Mucosal Healing in Ulcerative Colitis
Klaus Theede et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2015)
High Within-day Variability of Fecal Calprotectin Levels in Patients with Active Ulcerative Colitis: What Is the Best Timing for Stool Sampling?
Margalida Calafat et al.
INFLAMMATORY BOWEL DISEASES (2015)
Prediction of Endoscopic Disease Activity in Ulcerative Colitis by Two Different Assays for Fecal Calprotectin
Vendel Kristensen et al.
JOURNAL OF CROHNS & COLITIS (2015)
Comparison of two immunoassays for measurement of faecal calprotectin in detection of inflammatory bowel disease: (pre)-analytical and diagnostic performance characteristics
Matthijs Oyaert et al.
CLINICAL CHEMISTRY AND LABORATORY MEDICINE (2014)
Results from the 2nd Scientific Workshop of the ECCO (I): Impact of mucosal healing on the course of inflammatory bowel disease
Laurent Peyrin-Biroulet et al.
JOURNAL OF CROHNS & COLITIS (2011)